XML 44 R19.htm IDEA: XBRL DOCUMENT v3.20.1
Income Taxes
 3 Months Ended
Mar. 31, 2020
Accrued Income Taxes [Abstract]  
Income Taxes Income Taxes

Income tax expense attributable to our earnings (loss) from continuing operations before income taxes differs from the amounts computed using the applicable income tax rate as a result of the following factors:
 
Three months ended March 31,
 
2020
 
2019
 
in millions
 
 
 
 
Computed “expected” tax benefit (expense) (a)
$
(192.1
)
 
$
53.0

Non-deductible or non-taxable foreign currency exchange results
153.6

 
33.0

Change in valuation allowances
(88.7
)
 
(12.6
)
Tax benefit associated with technology innovation (b)
44.8

 
—

Enacted tax law and rate changes
36.1

 
(9.4
)
Non-deductible or non-taxable interest and other items
(20.4
)
 
(22.8
)
International rate differences (c)
(16.1
)
 
12.2

Basis and other differences in the treatment of items associated with investments in subsidiaries and affiliates (d)
3.1

 
(79.1
)
Other, net
(0.4
)
 
(2.1
)
Total income tax expense
$
(80.1
)
 
$
(27.8
)
_______________

(a)
The statutory or “expected” tax rates are the U.K. rates of 17.5% for the 2020 period and 19.0% for the 2019 period. The statutory rate for the 2020 period represents the blended rate in effect for the year ended December 31, 2020 based on the 19.0% statutory rate that was in effect for the first quarter of 2020 and the 17.0% statutory rate that is in effect for the remainder of 2020. In March 2020, it was announced that the U.K. corporate tax rate will remain at 19.0% and not reduce to 17.0% from April 1, 2020. The U.K. rate change has yet to be enacted; therefore, the impact on our deferred tax balances will not be recorded until the quarter of enactment.

(b)
Amount reflects the recognition of the innovation income tax deduction in Belgium, including the one-time effect of deductions related to prior periods.

(c)
Amounts reflect adjustments (either a benefit or expense) to the “expected” tax benefit (expense) for statutory rates in jurisdictions in which we operate outside of the U.K.

(d)
These amounts reflect the net impact of differences in the treatment of income and loss items between financial reporting and tax accounting related to investments in subsidiaries and affiliates including the effects of foreign earnings.

As of March 31, 2020, our unrecognized tax benefits of $647.7 million included $521.5 million of unrecognized tax benefits that would have a favorable impact on our effective income tax rate if ultimately recognized, after considering amounts that we would expect to be offset by valuation allowances and other factors.

During the next 12 months, it is reasonably possible that the resolution of ongoing examinations by tax authorities, as well as the expiration of statutes of limitation and other items, could result in reductions to our unrecognized tax benefits related to tax positions taken as of March 31, 2020. The amount of any such reductions could range up to $274.0 million, of which substantially all would have a positive impact on our effective tax rate. Other than the potential impacts of these ongoing examinations and the expected expiration of certain statutes of limitation, we do not expect any material changes to our unrecognized tax benefits during the next 12 months. No assurance can be given as to the nature or impact of any changes in our unrecognized tax positions during the next 12 months.

Certain of our subsidiaries are currently involved in income tax examinations in various jurisdictions in which we operate, including the Netherlands, Poland, the U.K. and the U.S. While we do not expect adjustments from the foregoing examinations to have a material impact on our consolidated financial position, results of operations or cash flows, no assurance can be given that this will be the case given the amounts involved and the complex nature of the related issues.